VitaSpring Biomedical Co. Ltd.
VSBC · OTC
10/31/2022 | 7/31/2022 | 4/30/2022 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $3 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -57.3% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 38.1% | 41.9% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 23.3% | 34.2% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 18.6% | 27% |
| EPS Diluted | -0.001 | -0.001 | 0.001 | 0.005 |
| % Growth | 0% | -153.8% | -71.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |